Coordination of PAR and Ub signaling in mitochondria
线粒体中 PAR 和 Ub 信号传导的协调
基本信息
- 批准号:10623889
- 负责人:
- 金额:$ 43.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:ADP ribosylationAddressAreaCell DeathCell NucleusCommunicationComplementDedicationsDepartment of DefenseDiseaseEnzymesEukaryotic CellFutureGPS2 geneGene Expression RegulationGenetic TranscriptionGenome StabilityGenomicsHomeostasisInnate Immune ResponseLinkMediatingMetabolicMetabolic ControlMetabolic PathwayMitochondriaMitochondrial ProteinsMolecularNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of General Medical SciencesNatural ImmunityNuclearNutrient availabilityObesityOrganellesOxidative StressPathway interactionsPhysiologicalPlayPositioning AttributePost-Translational Protein ProcessingProcessProductionRegulationResearchRoleSignal TransductionStressTherapeuticTransferaseTranslational RegulationTranslationsUbiquitinUbiquitinationWorkbiological adaptation to stressinhibitorinsightmalignant breast neoplasmprogramsresponsetargeted treatmenttranslational potential
项目摘要
Project Summary/Abstract
Over the past 10 years, our research program has aimed at discovering molecular mechanisms that control
metabolic adaptation in response to nutrient availability, cellular differentiation, and oxidative stress through
genomic reprogramming. With NIGMS support, we have made significant contributions to identifying
mechanisms responsible for the coordinated regulation of gene transcription and translation during the
Mitochondrial Stress Response (MSR). Our work has identified a key role for non-degradative ubiquitination in
both processes, showing that the regulated shuttling of GPS2 – an endogenous inhibitor of K63 ubiquitination –
between mitochondria and nucleus is an essential strategy for maintaining mitochondrial homeostasis. As a
complement to these mechanistic studies, we also investigated – in projects supported by NIDDK and the
Department of Defense – the physiological relevance and translational potential GPS2-mediated regulation of
ubiquitin signaling in breast cancer and obesity-associated disorders. Together, these studies have revealed the
importance of GPS2-mediated restriction of K63Ub signaling in promoting metabolic adaptation and
mitochondria remodeling during stress and cellular differentiation. This large body of work highlights our
expertise in the field and our unique position to further investigate the crosstalk between this newly identified
pathway and other PTMs involved in regulating mitochondrial function. In particular, we will focus our future
studies on the crosstalk between ubiquitination and ADP-ribosylation. These PTMs work in tandem in the
regulation of nuclear genome stability, innate immunity and stress-induced translational regulation. However,
their relationship in regulating mitochondrial function has not yet been investigated. In fact, although the presence
of ADP-ribosylation activity in mitochondria was known for decades, the identity of the mitochondrial ART
enzyme/s has been elusive, hindering more detailed studies on the role and regulation of mitochondrial proteins
through ADP-ribosylation. As we recently identified NEURL4 as a mitochondria-dedicated ADP-ribosyl
transferase under the regulation of stress-induced and GPS2-mediated reprogramming, we are now in the
position of carrying those studies. We propose a research plan spanning two major areas:1) Investigating the
spatial and functional regulation of mitochondria retrograde signaling in response to mitochondrial stress and 2)
Exploring the crosstalk between ubiquitination and ADP-ribosylation in regulating mitochondrial homeostasis.
Our research plan addresses three key problems: i) the spatial regulation of mitochondria retrograde signaling;
ii) the functional contribution of mitochondria retrograde signaling to the regulation of ADP-ribosylation and
ubiquitination across subcellular compartments; iii) the molecular mechanisms underlying the coordinated
regulation of ADP-ribosylation/ ubiquitination. Successful completion of the proposed studies will lead to a better
understanding of the mechanisms regulating mitochondria homeostasis through post-translational modifications
and possibly reveal regulatory strategies to be targeted for therapeutic purposes.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VALENTINA PERISSI其他文献
VALENTINA PERISSI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VALENTINA PERISSI', 18)}}的其他基金
Regulation of mitochondrial homeostasis through retrograde signaling
通过逆行信号调节线粒体稳态
- 批准号:
9924614 - 财政年份:2018
- 资助金额:
$ 43.14万 - 项目类别:
Regulation of mitochondrial homeostasis through retrograde signaling
通过逆行信号调节线粒体稳态
- 批准号:
10133090 - 财政年份:2018
- 资助金额:
$ 43.14万 - 项目类别:
Ubiquitin-dependent regulation of inflammation and insulin resistance
炎症和胰岛素抵抗的泛素依赖性调节
- 批准号:
9243244 - 财政年份:2014
- 资助金额:
$ 43.14万 - 项目类别:
Ubiquitin-dependent regulation of inflammation and insulin resistance
炎症和胰岛素抵抗的泛素依赖性调节
- 批准号:
9040938 - 财政年份:2014
- 资助金额:
$ 43.14万 - 项目类别:
Role of the NCoR corepressor complex in the development of insulin resistance
NCoR 辅阻遏物复合物在胰岛素抵抗发展中的作用
- 批准号:
8328959 - 财政年份:2010
- 资助金额:
$ 43.14万 - 项目类别:
Role of the NCoR corepressor complex in the development of insulin resistance
NCoR 辅阻遏物复合物在胰岛素抵抗发展中的作用
- 批准号:
8149970 - 财政年份:2010
- 资助金额:
$ 43.14万 - 项目类别:
Role of the NCoR corepressor complex in the development of insulin resistance
NCoR 辅阻遏物复合物在胰岛素抵抗发展中的作用
- 批准号:
8138837 - 财政年份:2010
- 资助金额:
$ 43.14万 - 项目类别:
Role of the NCoR corepressor complex in the development of insulin resistance
NCoR 辅阻遏物复合物在胰岛素抵抗发展中的作用
- 批准号:
7300065 - 财政年份:2007
- 资助金额:
$ 43.14万 - 项目类别:
Role of the NCoR corepressor complex in the development of insulin resistance
NCoR 辅阻遏物复合物在胰岛素抵抗发展中的作用
- 批准号:
7456334 - 财政年份:2007
- 资助金额:
$ 43.14万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 43.14万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 43.14万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 43.14万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 43.14万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 43.14万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 43.14万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 43.14万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 43.14万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 43.14万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 43.14万 - 项目类别:
Research Grant